{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:33:48Z","timestamp":1766378028060,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00345-019-03003-2","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T20:01:49Z","timestamp":1574280109000},"page":"2227-2236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-0169","authenticated-orcid":false,"given":"Karl H.","family":"Tully","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke J.","family":"Krimphove MD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Noldus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Mossanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"issue":"1","key":"3003_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62(1):100\u2013114. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.030","journal-title":"Eur Urol"},{"issue":"4","key":"3003_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.urology.2010.04.020","volume":"76","author":"R Abouassaly","year":"2010","unstructured":"Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 76(4):895\u2013901. https:\/\/doi.org\/10.1016\/j.urology.2010.04.020","journal-title":"Urology"},{"issue":"9","key":"3003_CR3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.6004\/jnccn.2018.0072","volume":"16","author":"TW Flaig","year":"2018","unstructured":"Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA (2018) NCCN guidelines insights: bladder cancer, version 5.2018. J Natl Compr Cancer Netw 16(9):1041\u20131053. https:\/\/doi.org\/10.6004\/jnccn.2018.0072","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"3003_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 update. Eur Urol 73(1):111\u2013122. https:\/\/doi.org\/10.1016\/j.eururo.2017.07.036","journal-title":"Eur Urol"},{"key":"3003_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comperat EM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 71:462\u2013475","journal-title":"Eur Urol."},{"issue":"4","key":"3003_CR6","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martinez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61(4):818\u2013825. https:\/\/doi.org\/10.1016\/j.eururo.2012.01.021","journal-title":"Eur Urol"},{"issue":"2","key":"3003_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.eururo.2012.01.019","volume":"62","author":"SF Shariat","year":"2012","unstructured":"Shariat SF, Zigeuner R, Rink M, Margulis V, Hansen J, Kikuchi E, Kassouf W, Raman JD, Remzi M, Koppie TM, Bensalah K, Guo CC, Mikami S, Sircar K, Ng CK, Haitel A, Kabbani W, Chun FK, Wood CG, Scherr DS, Karakiewicz PI, Langner C (2012) Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol 62(2):224\u2013231. https:\/\/doi.org\/10.1016\/j.eururo.2012.01.019","journal-title":"Eur Urol"},{"key":"3003_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.urology.2016.07.036","volume":"100","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Yasser Hussein MI, Vavassori I, Barni S (2017) Prognostic factors of overall survival in upper urinary tract carcinoma: a systematic review and meta-analysis. Urology 100:9\u201315. https:\/\/doi.org\/10.1016\/j.urology.2016.07.036","journal-title":"Urology"},{"key":"3003_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31952","author":"S Berg","year":"2019","unstructured":"Berg S, D\u2019Andrea D, Vetterlein MW, Cole AP, Fletcher SA, Krimphove MJ, Marchese M, Lipsitz SR, Sonpavde G, Noldus J, Shariat SF, Kibel AS, Trinh QD, Mossanen M (2019) Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: does histologic subtype matter? Cancer. https:\/\/doi.org\/10.1002\/cncr.31952","journal-title":"Cancer"},{"issue":"22","key":"3003_CR10","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1002\/cncr.30907","volume":"123","author":"MW Vetterlein","year":"2017","unstructured":"Vetterlein MW, Wankowicz SAM, Seisen T, Lander R, Loppenberg B, Chun FK, Menon M, Sun M, Barletta JA, Choueiri TK, Bellmunt J, Trinh QD, Preston MA (2017) Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer 123(22):4346\u20134355. https:\/\/doi.org\/10.1002\/cncr.30907","journal-title":"Cancer"},{"issue":"8","key":"3003_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","volume":"49","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49(8):1889\u20131897. https:\/\/doi.org\/10.1016\/j.ejca.2013.02.001","journal-title":"Eur J Cancer"},{"issue":"2","key":"3003_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","volume":"188","author":"M Rink","year":"2012","unstructured":"Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188(2):398\u2013404. https:\/\/doi.org\/10.1016\/j.juro.2012.04.009","journal-title":"J Urol"},{"issue":"6_suppl","key":"3003_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1200\/jco.2018.36.6_suppl.407","volume":"36","author":"AJ Birtle","year":"2018","unstructured":"Birtle AJ, Chester JD, Jones RJ, Johnson M, Hill M, Bryan RT, Catto J, Donovan J, French A, Harris C, Keeley F, Kockelbergh R, Powles T, Todd R, Tregellas L, Wilson C, Winterbottom A, Lewis R, Hall E (2018) Results of POUT: a phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). J Clin Oncol 36(6_suppl):407. https:\/\/doi.org\/10.1200\/jco.2018.36.6_suppl.407","journal-title":"J Clin Oncol"},{"issue":"4","key":"3003_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.urolonc.2017.08.008","volume":"36","author":"AP Cole","year":"2018","unstructured":"Cole AP, Friedlander DF, Trinh QD (2018) Secondary data sources for health services research in urologic oncology. Urol Oncol 36(4):165\u2013173. https:\/\/doi.org\/10.1016\/j.urolonc.2017.08.008","journal-title":"Urol Oncol"},{"key":"3003_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcrc.2016.07.017","volume":"36","author":"M Jones","year":"2016","unstructured":"Jones M, Fowler R (2016) Immortal time bias in observational studies of time-to-event outcomes. J Crit Care 36:195\u2013199. https:\/\/doi.org\/10.1016\/j.jcrc.2016.07.017","journal-title":"J Crit Care"},{"issue":"36","key":"3003_CR16","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199\u20136206. https:\/\/doi.org\/10.1200\/JCO.2009.23.4799","journal-title":"J Clin Oncol"},{"issue":"7","key":"3003_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.urolonc.2017.02.010","volume":"35","author":"JK Kim","year":"2017","unstructured":"Kim JK, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH (2017) Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Urol Oncol 35(7):415\u2013459. https:\/\/doi.org\/10.1016\/j.urolonc.2017.02.010","journal-title":"Urol Oncol"},{"issue":"2","key":"3003_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s10147-014-0721-3","volume":"20","author":"S Sakano","year":"2015","unstructured":"Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y, Nasu T, Baba Y, Shimabukuro T, Suga A, Yamamoto M, Aoki A, Takai K, Yoshihiro S, Oba K, Yamaguchi Uro-Oncology G (2015) Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma. Int J Clin Oncol 20(2):362\u2013368. https:\/\/doi.org\/10.1007\/s10147-014-0721-3","journal-title":"Int J Clin Oncol"},{"key":"3003_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14704","author":"L Stroman","year":"2019","unstructured":"Stroman L, Nair R, Russell B, Malik N, Desai A, Chandra A, Thurairaja R, Dasgupta P, Khan MS, Malde S (2019) The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy. BJU Int. https:\/\/doi.org\/10.1111\/bju.14704","journal-title":"BJU Int"},{"key":"3003_CR20","volume-title":"The kidneys and the renal system, The human body","author":"K Rogers","year":"2012","unstructured":"Rogers K (2012) The kidneys and the renal system, The human body, 1st edn. Rosen Educational Services, New York","edition":"1"},{"key":"3003_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2018.11.015","author":"HS Chung","year":"2019","unstructured":"Chung HS, Hwang EC, Kim MS, Yu SH, Jung SI, Kang TW, Choi C, Choi SH, Kwon TG, Noh JH, Kim MK, Cho WJ, Kang SG, Kang SH, Cheon J, Seo IY, Chung H, Kim HS, Lee CH, Ku JY, Ha HK, Kim BH, Jeong CW, Ku JH, Kwak C, Kwon D (2019) Effects of variant histology on the oncologic outcomes of patients with upper urinary tract carcinoma after radical nephroureterectomy: a propensity score-matched analysis. Clin Genitourin Cancer. https:\/\/doi.org\/10.1016\/j.clgc.2018.11.015","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"3003_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00345-013-1141-0","volume":"32","author":"A Masson-Lecomte","year":"2014","unstructured":"Masson-Lecomte A, Colin P, Bozzini G, Nison L, de La Taille A, Comperat E, Zerbib M, Rozet F, Cathelineau X, Valeri A, Ruffion A, Guy L, Droupy S, Cussenot O, Roupret M (2014) Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 32(2):531\u2013537. https:\/\/doi.org\/10.1007\/s00345-013-1141-0","journal-title":"World J Urol"},{"issue":"15","key":"3003_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.purol.2014.07.003","volume":"24","author":"J Varinot","year":"2014","unstructured":"Varinot J, Colin P, Roupret M, Leroy X, Comperat E (2014) Pathologic analysis of upper tract urothelial carcinomas: state of the art review for the yearly scientific report of the French National Association of Urology. Prog Urol 24(15):954\u2013965. https:\/\/doi.org\/10.1016\/j.purol.2014.07.003","journal-title":"Prog Urol"},{"issue":"1","key":"3003_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.urolonc.2005.05.027","volume":"24","author":"MS Zaghloul","year":"2006","unstructured":"Zaghloul MS, Nouh A, Nazmy M, Ramzy S, Zaghloul AS, Sedira MA, Khalil E (2006) Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 24(1):13\u201320. https:\/\/doi.org\/10.1016\/j.urolonc.2005.05.027","journal-title":"Urol Oncol"},{"issue":"3","key":"3003_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11912-019-0772-8","volume":"21","author":"JT Matulay","year":"2019","unstructured":"Matulay JT, Narayan VM, Kamat AM (2019) Clinical and genomic considerations for variant histology in bladder cancer. Curr Oncol Rep 21(3):23. https:\/\/doi.org\/10.1007\/s11912-019-0772-8","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"3003_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00345-015-1715-0","volume":"34","author":"Q Tang","year":"2016","unstructured":"Tang Q, Xiong G, Li X, Fang D, Xi C, Zhang L, Yang K, Yao L, Zhang C, Yu W, He Q, Gong K, He Z, Zhou L (2016) The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy. World J Urol 34(6):871\u2013877. https:\/\/doi.org\/10.1007\/s00345-015-1715-0","journal-title":"World J Urol"},{"issue":"3","key":"3003_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","volume":"66","author":"JJ Leow","year":"2014","unstructured":"Leow JJ, Martin-Doyle W, Fay AP, Choueiri TK, Chang SL, Bellmunt J (2014) A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 66(3):529\u2013541. https:\/\/doi.org\/10.1016\/j.eururo.2014.03.003","journal-title":"Eur Urol"},{"issue":"10","key":"3003_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11912-018-0727-5","volume":"20","author":"DJ McConkey","year":"2018","unstructured":"McConkey DJ, Choi W (2018) Molecular subtypes of bladder cancer. Curr Oncol Rep 20(10):77. https:\/\/doi.org\/10.1007\/s11912-018-0727-5","journal-title":"Curr Oncol Rep"},{"issue":"7492","key":"3003_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315\u2013322. https:\/\/doi.org\/10.1038\/nature12965","journal-title":"Nature"},{"issue":"4","key":"3003_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","volume":"72","author":"R Seiler","year":"2017","unstructured":"Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Sjodahl G, Kardos J, Hoadley KA, Lerner SP, McConkey DJ, Choi W, Kim WY, Kiss B, Thalmann GN, Todenhofer T, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall\u2019Era M, van der Heijden MS, Black PC (2017) Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol 72(4):544\u2013554. https:\/\/doi.org\/10.1016\/j.eururo.2017.03.030","journal-title":"Eur Urol"},{"issue":"1","key":"3003_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/S1677-5538.IBJU.2017.0204","volume":"44","author":"RL Favaretto","year":"2018","unstructured":"Favaretto RL, Zequi SC, Oliveira RAR, Santana T, Costa WH, Cunha IW, Guimaraes GC (2018) Tissue-based molecular markers in upper tract urothelial carcinoma and their prognostic implications. Int Braz J Urol 44(1):22\u201337. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2017.0204","journal-title":"Int Braz J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-03003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-03003-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-03003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:30:11Z","timestamp":1605745811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-03003-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-03003-2","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"type":"print","value":"0724-4983"},{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Quoc-Dien Trinh reports personal fees from Astellas, Bayer, Janssen, Insightec and Intuitive Surgical. Adam S. Kibel reports consulting fees from Sanofi, Dendreon, Tokai, and Profound.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}